Moreover, it was recently demonstrated that obesity generated by leptin deficiency in mice can affect KRAS-induced pancreatic cancer progression not through impaired LEPR-signalling but, rather, through an obesity-specific mechanism involving aberrant endocrine–exocrine signalling in the adapting pancreatic beta cells14. This evidence concerns the gene LEPR and pancreatic neoplasm.